Q BioMed Inc.

Q BioMed Inc.
Stock Exchange Other OTC
Market Cap
$20.22 M
Shares Outstanding
14.65 M
Public Float
9.21 M


366 Madison Avenue
New York New York 10017
United States
Employees -
Website http://www.qbiomed.com
Updated 07/08/2019
Q BioMed, Inc. operates as a biomedical acceleration and development company. It is focused on acquiring and in-licensing pre-clinical, clinical-stage and approved life sciences therapeutic products. The company products include Strontium 89, QBM-001, Uttroside-B, and MAN 01.


View All

Denis D. Corin
Chairman, President, CEO, CFO & CAO
William S. Rosenstadt
Director, Chief Legal Officer & General Counsel